These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Regulation of kynurenic acid synthesis in C6 glioma cells. Kocki T; Dolińska M; Dybel A; Urbańska EM; Turski WA; Albrecht J J Neurosci Res; 2002 Jun; 68(5):622-6. PubMed ID: 12111852 [TBL] [Abstract][Full Text] [Related]
32. beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling. Luchowska E; Kloc R; Olajossy B; Wnuk S; Wielosz M; Owe-Larsson B; Urbanska EM Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):519-29. PubMed ID: 19439240 [TBL] [Abstract][Full Text] [Related]
33. Changes of kynurenic acid content in the rat and chicken retina during ontogeny. Rejdak R; Zarnowski T; Turski WA; Kocki T; Zagorski Z; Guenther E; Kohler K; Zrenner E Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):687-91. PubMed ID: 12192464 [TBL] [Abstract][Full Text] [Related]
34. Effect of pesticides on kynurenic acid production in rat brain slices. Zielińska E; Kocki T; Saran T; Borbely S; Kuc D; Vilagi I; Urbańska EM; Turski WA Ann Agric Environ Med; 2005; 12(2):177-9. PubMed ID: 16457470 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of kynurenic acid in stroke: An endogenous neuroprotector? Mangas A; Yajeya J; González N; Ruiz I; Duleu S; Geffard M; Coveñas R Ann Anat; 2017 May; 211():33-38. PubMed ID: 28163204 [TBL] [Abstract][Full Text] [Related]
36. The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction. Klein C; Patte-Mensah C; Taleb O; Bourguignon JJ; Schmitt M; Bihel F; Maitre M; Mensah-Nyagan AG Neuropharmacology; 2013 Jul; 70():254-60. PubMed ID: 23422298 [TBL] [Abstract][Full Text] [Related]
37. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia. Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185 [TBL] [Abstract][Full Text] [Related]
38. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy. Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078 [TBL] [Abstract][Full Text] [Related]
39. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain. Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317 [TBL] [Abstract][Full Text] [Related]
40. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat. Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]